Greek Comedy or Tragedy?

The drama in Europe is a main headline when it comes to global markets this week.

Will Greece de-couple from the Euro like Switzerland did? Will a debt deal be reached? How will the new left leaning Syriza regime end austerity without another huge crash? Will this unfold as a comedy or tragedy?

These are question to ponder and really outside of our realm to try and even answer. If we focus back in on the small cap world you may remember a ‘pan’, in the words of this week’s Guide, we made way back in late August 2013. DryShips, Inc. (NASDAQ – DRYS - $1.00) is a shipping firm specializing in dry bulk and petroleum cargo while also providing offshore drilling services. We made the call that this stock could be used as a small cap bellwether for Europe.

Well the bell has been tolled over the last six months as the stock has plummeted from a relative $3.36 high. Chalk it up to low oil and gas and the ‘new’ Greek crisis. We believe opportunity exists here to make money on a quick trade for a couple reasons. Inevitably, a deal will be made with the rest of the EU. Historical precedence just gives a feeling here. The stock will pop for sure on this news. Additionally, the short term technical EMA indicates a very bullish signal. We think DRYS can climb to $1.50 in the middle of 2Q15.

Back here in the States there was an awful tragedy with a ‘shipping’ company as a huge train derailment in West, Virginia after an explosion on car carrying oil. The CSX Corporation (NYSE – CSX - $35.85) was the railroad services party involved. Fortunately, no major injuries or deaths have been reported but this sort of incident can be a PR disaster for companies. CSX has gotten ahead of the curve be establishing a Community Outreach Center in the region to help area residents.

This stock skyrocketed and could almost be considered somewhat of a proxy here in the United States. CSX is up 32% over the last year and was hit less than 1% yesterday on the news. The stock is still very bullish on short, intermediate, and long term EMA. This could be one to watch for another trade. If the PR campaign goes sour and the stock loses ground in the short term, a buying opportunity may present itself over the next few days. Even in the long term, CSX appears to be a buy at a quick glance with a forward P/E of 14 and a trailing P/E of 18 and 5-year PEG of 1.6. Operating and gross margins of 29% and 38% are also well above industry averages of 11% and 30% respectively. CSX could reach $38 later on this year.

Have a great day!

Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.

Disclaimer:

This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports. 

Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.

It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations. 

The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.

This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.

ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS   INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.

For more information, visit our Disclaimer: www.goldmanresearch.com